Navigation Links
Anastrozole Is A More Effective Cancer Drug

The NHS of the UK has come under increased pressure from charities for making it possible to increase access to a new breast cancer drug which is better than tamoxifen//. Women suffering from the early stages of the disease are treated with tamoxifen. If the women who were treated with tamoxifen for two years were to switch over to anastrozole, one of the new drugs, they are more likely to be alive after a period of two and a half years, according to the research.

In the case of the patients who had switched drugs, the deaths had gone down by 29%. The study was conducted on over 4,000 women across Italy, Germany, and Australia. The deaths among the 2,009 women who changed over to anastrozole was 66, while in the case of tamoxifen, it was 90.

AstraZeneca is marketing anastrozole as Arimidex, and this has received the support of the NHS in Scotland. Tamoxifen administered over 5 years after initial surgery brought down the recurrence of breast cancer by 50%, and administering anastrozole reduces it by a further 26%.

In the UK alone as many as 32,000 postmenopausal women are diagnosed with breast cancer every year, and as three quarters of the tumors are due to sex hormone oestrogen, they are ideal for the new treatment. Arimidex belongs to the aromotase inhibitors class of drugs which prevents the further development of oestrogen.

The treatment costs £68 per month, and it is very much more expensive than tamoxifen. Aromatase inhibitors prevent estrogen and also do not increase the possibilities of endometrial cancer and blood clots. The three brands of this medicine are Novartis Pharmaceuticals’ Femara, Pfizer Inc.’s Aromasin and AstraZeneca PLC’s Arimidex
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: